Back to Search
Start Over
O-15 Randomized, phase 3 study of second-line tislelizumab vs chemotherapy in advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302) in the overall population and Europe/North America subgroup.
- Source :
-
Annals of Oncology . 2021 Supplement 3, Vol. 32, pS225-S225. 1p. - Publication Year :
- 2021
- Subjects :
- *TREATMENT of esophageal cancer
*CANCER chemotherapy
*SQUAMOUS cell carcinoma
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152687487
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.05.807